what compound is cagrilintide | C194H312N54O59S2 | CID 171397054 Cagrilintide 10mg | Research Peptide

[1] The more advanced regulatory activity belongs to the combination product CagriSema (cagrilintide plus semaglutide), which reached Phase 3 and for which a New Drug Application was reported to have been filed with the FDA in late 2025

Gutbrain signaling research: Exploring how amylin-related signaling contributes to appetite and satiety pathways in brain regions involved in hunger regulation

But those are different trials with different durations and doses, and cagrilintides strongest data are as the CagriSema combination, so any ranking is a cross-trial inference rather than a proven result

Retatrutide = three axes in one molecule (GIP + GLP-1 + glucagon), both sides of energy balance